openPR Logo
Press release

Multiple Myeloma Drugs Market Trends Show Rapid Growth by 2021-2026 | Amgen, J & J, Celgene, Takeda, Novartis, Daiichi Sankyo, Merck, AB Science, Teva, PharmaMar

03-05-2021 05:38 PM CET | Health & Medicine

Press release from: Business Industry Reports

Multiple Myeloma Drugs

Multiple Myeloma Drugs

The global Multiple Myeloma Drugs market size is projected to grow from 2021 to 2026. The demand for Multiple Myeloma Drugs can be attributed to patient benefits, growth of the manufacturing sector, increasing production and growing capacity in healthcare industry, and healthy growth of pharmaceutical and food & beverage industry in developing countries, are supporting the growth of the Multiple Myeloma Drugs market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/284200 .

Pandemic impact on the Global Multiple Myeloma Drugs Market:

The declining prices, supply-demand gap, and COVID-19 pandemic impact had severe impact on the Multiple Myeloma Drugs market. Due to the COVID-19 pandemic, the demand for Multiple Myeloma Drugs has been increasing due to rise in the healthcare throughput, suspension of manufacturing activities, disruption of supply chain, and postponement of the expansion projects across the globe. However, during pandemic period, the growing demand from the food & beverage, and pharmaceutical industries supports to offset the marginal decline in demand caused due to slowdown in the manufacturing sector across the globe.

Global Multiple Myeloma Drugs Market Dynamics:

The plasma cells are a type of white blood cell in the bone marrow. With this condition, a group of plasma cells becomes cancerous and multiplies. The disease can damage the bones, immune system, kidneys and red blood cell count. Symptoms may not be present or may be non-specific, such as loss of appetite, bone pain and fever. Treatments include medication, chemotherapy, corticosteroids, radiation or a stem-cell transplant.

The report recognises major industry vendors, key regions, demand & supply, applications, innovations, revenue costs, and challenges. Information according to global Multiple Myeloma Drugs market segments such as geographies, applications, and industry by considering major players has been given. The report shows market effect factors analysis that precisely emphasizes technology progress/risk, consumer needs/customer preference changes, technology progress in a related industry that draws the growth factors of the market.

The evident quantitative as well as qualitative insights about the Global Multiple Myeloma Drugs market are covered in the report along with forecast analysis of all the Global Multiple Myeloma Drugs market that expected to modify the market in the future are described in detail. The segmental analysis also highlights details about different aspects that will influence the market.

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Multiple Myeloma Drugs Market Report 2021” @ https://www.businessindustryreports.com/buy-now/284200/single .

Multiple Myeloma Drugs Market Players:

Amgen
Johnson & Johnson
Celgene
Takeda Pharmaceutical
Novartis
Daiichi Sankyo
Merck
AB Science
Teva
PharmaMar

Product Type Segmentation:

Chemotherapy
Corticosteroids
Immunomodulators
Monoclonal Antibodies
Histone Deacetylase (HDAC) Inhibitors
Proteasome Inhibitors
Others

Industry Segmentation:

Men
Women

Segmentation by Regions:

On the basis of Regional analysis, North America and Europe holds major share in global Multiple Myeloma Drugs market. Moreover, Asia-Pacific is expected to record higher growth rate in Multiple Myeloma Drugs Market during the forecast year.

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/284200 .

Top Industry News:

Merck Builds on Leadership in Head and Neck Cancer through Worldwide Licensing Agreement with Debiopharm for Pivotal-Stage Xevinapant on 01 March, 2021 -- Merck, a leading science and technology company, today announced a worldwide in-licensing agreement with Debiopharm, Lausanne, Switzerland, for the development and commercialization of xevinapant (Debio 1143). Xevinapant, a potent oral Inhibitor of Apoptosis Proteins (IAP) antagonist, is the only medicine in its class in late-stage clinical development and has the potential to be first in class. Xevinapant is currently being investigated in the Phase III TrilynX study for previously untreated high-risk locally advanced squamous cell carcinoma of the head and neck (LA SCCHN), in combination with platinum-based chemotherapy and standard fractionation intensity-modulated radiotherapy.

“As a leading science and technology company, we are constantly evolving our three business sectors to ensure we are best-positioned to create sustainable value. This includes the addition of highly promising technologies, such as the in-licensing of xevinapant. This late-stage asset complements our Healthcare pipeline, which will be one of Merck’s key growth drivers in the coming years,” said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck.

“By bringing our expertise and heritage in head and neck cancer to the development of xevinapant, we have the opportunity to explore an important new treatment option in an area of high unmet need where other approaches, including immunotherapy, have seen limited success. The promising long-term efficacy of xevinapant in the Phase II trial suggests that antagonism of IAP has the potential to be a transformative approach in this cancer,” said Peter Guenter, Member of the Executive Board of Merck and CEO Healthcare. “Looking forward, we will continue to pursue opportunities to augment the in-house innovations in our oncology portfolio with new solutions for patients with cancer.”

About us

BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Multiple Myeloma Drugs Market Trends Show Rapid Growth by 2021-2026 | Amgen, J & J, Celgene, Takeda, Novartis, Daiichi Sankyo, Merck, AB Science, Teva, PharmaMar here

News-ID: 2253031 • Views:

More Releases from Business Industry Reports

Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo International, Nuvo Pharma, Ferndale Pharma, Galen, Jazz Pharma, Paladin Labs, St Renatus, MSK Pharma
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size and Leading Players (Lockheed Martin, BAE System, Boeing, General Dynamic, Raytheon) | Forecast to 2025
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market: This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization. According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growth by Top Key Company’s - J&J, Medtronic, B Braun, Boston Medical, Integra, Stryker, Zimmer, CONMED
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market: This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization. According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key Players - Apple, Fitbit, Synbiota, THE ODIN, HVMN, Thync Global, Moodmetric
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis: The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast

All 5 Releases


More Releases for Multiple

Massive MIMO (Multiple-input multiple-output) Market 2022-2028 | Detailed Report
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Massive MIMO (Multiple-input multiple-output) industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Massive MIMO (Multiple-input multiple-output) market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Massive MIMO (Multiple-input multiple-output)
Multiple Sclerosis Therapeutics Market – Increasing prevalence of multiple scl …
Multiple Sclerosis Therapeutics Market report is a exploration database spread across colorful runners with multiple tables and numbers in it. The exploration covers a precious source of perceptive information for business strategists. Multiple Sclerosis Therapeutics Industry provides the overview with growth analysis and literal & futuristic cost, profit, demand and force data (as applicable). The exploration judges give an elegant description of the value chain and its distributor analysis. This comprehensive
Global Multiple Sclerosis Market Size, Global Multiple Sclerosis Market Share, G …
The Global Multiple Sclerosis Market Size is majorly driven by the factors such as rising number of consolidations between the market players for exploring the untapped market opportunity across the world. Request for Sample of This Research Report @ https://bit.ly/2Nh6b4d Top Key Player:- Hoffmann-La Roche Ltd. Bayer Healthcare AG Teva Pharmaceuticals GlaxoSmithKline AbbVie Inc. Sonafi Pasteur Pfizer Inc. Merck & Company Novartis AG AB Science Opexa Multiple Sclerosis (MS) is a disease in which the insulating covers of nerves and spinal cord are
Multiple Ion Beam Microscopes Market- Multiple Ion Beam Microscopes Have Huge Ap …
An ion beam is a kind of charged particle beam which consists of ions. With the advancement of nanotechnology new and advanced fabrication techniques are required which helps in production of functional features in much smaller scales. Advanced techniques are being used for applications in material science which uses image surfaces producing different features in a nanoscale. Gas field ion source technology has the capability of combining helium and neon
Smart Antenna Market Report 2018: Segmentation by Type (Switched Beam Smart Ante …
Global Smart Antenna market research report provides company profile for Cobham Antenna Systems(Suffolk, United Kingdom), Intel Corp.( Santa Clara, California, United States), Samsung Electronics CoLtd. ( Seoul, South Korea), ArrayComm LLC ( California, United States), Alcatel-Lucent International Holdings Inc.( Paris, France), Motorola Solutions Inc.( Illinois, the U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017,
Thermoseal Group Multiple Award Winners
For the second year in a row, Thermoseal Group is the winner of the coveted Glass and Glazing Industry’s G-Award for ‘Component Supplier of the Year’ as announced at the prestigious Gala Dinner held at the Hilton on Park Lane Hotel in London on Friday 18 November 2016. This was a great day for Thermoseal Group who were also announced winners at two other awards events held that day